Skip to content
User

Greenlight Capital IMVT trades

David Einhorn

David Einhorn ImmunovantInc stake

total: 364

Trades details

Total transactions:
2
New positions:
1
Reduced:
1
Held for:
0 quarters
Latest activity:
2026 Q3
According to 2026 Q3 report, David Einhorn holds 70,140 ImmunovantInc (IMVT) shares with a market value of roughly $2.37M accounting for 0.07% of the overall portfolio. Greenlight Capital first purchased IMVT in 2026 Q1, initially acquiring 93,520 shares. Since the initial investment in ImmunovantInc (IMVT), Greenlight Capital has made 1 more transaction.

How many IMVT shares does David Einhorn currently hold?

According to 2026 Q3 report, David Einhorn holds 70,140 shares of ImmunovantInc (IMVT), valued at around $2.37M.

When did David Einhorn buy ImmunovantInc (IMVT)?

David Einhorn first invested in ImmunovantInc (IMVT) in 2026 Q1 at the reported quarter-end price of $24.84 per share.

David Einhorn's historical trades in ImmunovantInc

2 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q3
0.07%
70,140
$33.78
$2,369,329
-25.00% (-23,380)
-0.02%
2026 Q1
0.07%
93,520
$24.84
$2,323,036
new
+0.07%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.